calcium acetate 667 MG Oral Capsule

1 INDICATIONS AND USAGE Calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). Calcium acetate is a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal disease. ( 1 )

chartwell rx, llc.

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] toxicity to various agents` `[4] nausea` `[5] completed suicide` `[6] dyspnoea` `[7] drug abuse` `[8] pain` `[9] diarrhoea` `[10] off label use`

5 years ago

CAPSULE WHITE CE 0191

16 HOW SUPPLIED/STORAGE AND HANDLING Each capsule for oral administration has a white body and cap imprinted in black ink on the cap with "CE"and body with "0191" containing 667 mg

CALCIUM ACETATE (anhydrous; Ca(CH 3 COO) 2 ; MW=158.17 grams) equal to 169 mg (8.45 mEq) calcium. capsules NDC 62135-191-30 Bottles of 30 capsules NDC 62135-191-22 Bottles of 200 capsules NDC 62135-191-73 Bottles of 750 Storage: Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].

More pills like CAPSULE CE 0191

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

calcium acetate 667 MG Oral Capsule

FDA Reported Adverse Reactions [1] fatigue [2] drug ineffective [3] toxicity to various agents [4] nausea [5] completed suicide [6] dyspnoea [7] drug abuse [8] pain [9] diarrhoea [10] off label use

CAPSULE WHITE CE 0191

More pills like CAPSULE CE 0191

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] toxicity to various agents` `[4] nausea` `[5] completed suicide` `[6] dyspnoea` `[7] drug abuse` `[8] pain` `[9] diarrhoea` `[10] off label use`